SAM #HT942726RE009

Battlefield Analgesic Prototype Development for Defense Health Agency

The Defense Health Agency (DHA) is seeking innovative solutions for battlefield pain management: - Government Buyer: - Defense Health Agency (DHA), Research & Development Contracting Division 2, under the Defense Health Agency Contracting Activity (DHACA) - OEMs and Vendors: - No specific OEMs or vendors named; opportunity is open to all qualified manufacturers and developers - Products/Services Requested: - Development of an analgesic product (including combination products) for moderate to severe pain - Product must be suitable for use at the point of injury, during Tactical Combat Casualty Care, and/or Prolonged Casualty Care - Prototype development effort, not a procurement of existing products - Product must be developed through the FDA approval process - Emergency Use Authorization may be considered for early delivery - Unique/Notable Requirements: - Open competition to maximize innovation; up to two awards may be made - No specific part numbers, models, or purchase quantities provided - Focus on battlefield applicability and regulatory compliance (FDA approval) - Place of Performance: - Primary contracting office at Fort Detrick, Maryland - Place of performance in Frederick, Maryland

Description

The Defense Health Agency Contracting Activity (DHACA), Research & Development Contracting Division 2, intends to issue a Request for Prototype Proposal (RPP) on behalf of the Operational Medical Systems, Warfighter Protection and Acute Care Project Management Office for Battlefield Pain Management – Analgesic. The intent is to issue a competitive RPP for the development of an analgesic product with a moderate to severe pain indication through the Food and Drug Administration approval for use on the battlefield, at the point of injury, during Tactical Combat Casualty Care, and/or during Prolonged Casualty Care. The proposal will be open to any analgesic product, including combination products, to ensure that competition and innovation will be maximized. Subject to the availability of funds and evolving Government requirements, multiple awards may be made for the development of up to two products, with an Emergency Use Authorization as a potential strategy for early delivery to the Warfighter. DHACA intends to publish the RPP in Quarter 3 – Quarter 4, Fiscal Year 2026 with up to two awards expected to be delivered in Quarter 1 – Quarter 2, Fiscal Year 2027. No telephone calls will be accepted.

View original listing